CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2A Open-Label Trial to Assess the Safety of ZIMURA™ (Anti-C5) in Combination With EYLEA® in Treatment Experienced Subjects With Idiopathic Polypoidal Choroidal Vasculopathy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03374670
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:57.559095+00:00
Published At: 2024-02-21T00:00:00+00:00
Record Updated At: 2024-02-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Idiopathic Polypoidal Choroidal Vasculopathy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-02-21"
protocolSection.identificationModule.nctId: "NCT03374670"
protocolSection.identificationModule.officialTitle: "A Phase 2A Open-Label Trial to Assess the Safety of ZIMURA\u2122 (Anti-C5) in Combination With EYLEA\u00ae in Treatment Experienced Subjects With Idiopathic Polypoidal Choroidal Vasculopathy"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.